SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-21-055655
Filing Date
2021-11-01
Accepted
2021-11-01 08:30:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM F-1 ea149618-f1a1_nlspharma.htm F-1/A 302320
2 GRAPHIC image_001.jpg GRAPHIC 14048
3 GRAPHIC image_002.jpg GRAPHIC 14048
  Complete submission text file 0001213900-21-055655.txt   342221
Mailing Address ALTER POSTPLATZ 2 STANS V8 CH-6370
Business Address ALTER POSTPLATZ 2 STANS V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-260435 | Film No.: 211365404
SIC: 2834 Pharmaceutical Preparations